Gadoxetic Acid-Enhanced Liver MRI for Differentiating Metabolic Predominance in Hepatocellular Carcinoma on Dual-Tracer PET/CT
Academic Radiology · 2026-04 · 33 (4) · 1368-1377
DOI: 10.1016/j.acra.2025.12.044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Radiology, 2026-04. Verfasst von Jang Bae Moon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Chonnam National University Medical School and Hwasun Hospital, 58128, Republic of Korea (J.B.M., S.W.Y., C.L., S.Y.K…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Gadolinium DTPA, Positron Emission Tomography Computed Tomography. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare, Chonnam National University.
Abstract (Originalsprache)
RATIONALE AND OBJECTIVES: The metabolic predominance of hepatocellular carcinoma (HCC) on dual-tracer PET/CT with C-11 acetate and F-18 fluorodeoxyglucose (FDG) reflects tumor differentiation, but a practical MRI-based biomarker for predicting this phenotype remains needed. This study aimed to assess whether enhancement patterns on gadoxetic acid-enhanced liver MRI can differentiate the metabolic predominance of HCC. MATERIALS AND METHODS: This exploratory retrospective study included patients with HCC who underwent both dual-tracer PET/CT and liver MRI between January 2015 and December 2021. HCC lesions were categorized as acetate- or FDG-dominant based on tracer avidity. Signal intensity (SI) in each MRI phase was quantified using the percentage signal ratio (PSR), defined as the ratio of SI in adjacent normal liver parenchyma to that in the lesion. The area under the receiver operating characteristic curve (AUC) was measured to determine the MRI phase that best distinguished the metabolic predominance of HCC lesions. RESULTS: In 38 patients (mean age, 62.0±8.0 years) with 48 HCC lesions, median PSR values were lower in acetate-dominant group (28 lesions) than in FDG-dominant group (20 lesions) during the early arterial (64.7 vs. 113.9; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Chonnam National University Medical School and Hwasun Hospital, 58128, Republic of Korea (J.B.M., S.W.Y., C.L., S.Y.K.).
- Department of Radiology, Chonnam National University Medical School and Hwasun Hospital, 58128, Republic of Korea (S.H.H., S.W.K., J.K.).
- College of Pharmacy and Research Institute of Pharmaceutical Science, Gyeongsang National University, 52828, Republic of Korea (A.P., D.Y.K.).
- Department of Nuclear Medicine, Chonnam National University Medical School and Hwasun Hospital, 58128, Republic of Korea (J.B.M., S.W.Y., C.L., S.Y.K.). Electronic address: kwonsy@jnu.ac.kr.
Förderung
- Korea Health Industry Development Institute
- Ministry of Health and Welfare
- Chonnam National University
- Ministry of Science and ICT, South Korea
- National Research Foundation of Korea
- Chonnam National University Hwasun Hospital
Zitieren
APA
Moon, J. B., Heo, S. H., Kang, S. W., Kim, J., Yoo, S. W., Pyo, A., Kim, D. Y., Lee, C., & Kwon, S. Y. (2026). Gadoxetic Acid-Enhanced Liver MRI for Differentiating Metabolic Predominance in Hepatocellular Carcinoma on Dual-Tracer PET/CT. Academic Radiology, 33(4), 1368-1377. https://doi.org/10.1016/j.acra.2025.12.044
Vancouver
Moon JB, Heo SH, Kang SW, Kim J, Yoo SW, Pyo A, et al. Gadoxetic Acid-Enhanced Liver MRI for Differentiating Metabolic Predominance in Hepatocellular Carcinoma on Dual-Tracer PET/CT. Academic Radiology. 2026;33(4):1368-1377. doi:10.1016/j.acra.2025.12.044
BibTeX
@article{Moon2026,
author = {Moon, Jang Bae and Heo, Suk Hee and Kang, Seung Wan and Kim, Jihyun and Yoo, Su Woong and Pyo, Ayoung and Kim, Dong-Yeon and Lee, Changho and Kwon, Seong-Young},
title = {Gadoxetic Acid-Enhanced Liver MRI for Differentiating Metabolic Predominance in Hepatocellular Carcinoma on Dual-Tracer PET/CT},
journal = {Academic Radiology},
year = {2026},
volume = {33},
number = {4},
pages = {1368--1377},
doi = {10.1016/j.acra.2025.12.044}
}
EUVIMED